| Bioactivity | Mercaptoethylguanidine (MEG) dihydrobromide is selective inhibitor of the inducible nitric oxide synthase and peroxynitrite scavenger. Mercaptoethylguanidine (MEG) dihydrobromide has the potential for inflammatory bowel diseases research. |
| In Vivo | Mercaptoethylguanidine (MEG; 10 mg/kg i.v. b. i.d.) dihydrobromide significantly reduces the appearance of diarrhea and the loss of body weight in male rats with colitis[1]. Mercaptoethylguanidine (10 mg/kg/day; ip; for 5 days) dihydrobromide ameliorates oxidative stress parameters and antioxidant enzyme activities in forty-five Sprague-Dawley rats weighing 200 to 250 g with esophagus uninjured[2]. |
| Name | Mercaptoethylguanidine (MEG) (dihydrobromide) |
| CAS | 32665-11-5 |
| Formula | C3H11Br2N3S |
| Molar Mass | 281.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. B Zingarelli, et al. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther. 1998 Dec;287(3):1048-55. [2]. Ahmet Guven, et al. Mercaptoethylguanidine attenuates caustic esophageal injury in rats: a role for scavenging of peroxynitrite. J Pediatr Surg. 2011 Sep;46(9):1746-52. |